HeartSciences grants 117K options to execs and directors at $3.33 strike

HeartSciences Inc.

CEO Andrew Simpson and COO Mark Hilz each receive 45,000 options; CFO Danielle Watson receives 9,000.
Non-employee directors Brian Szymczak, Bruce Brent, and David R. Wells each receive 6,000 options.
All options have exercise price of $3.33 per share; executive options vest over 3 years with 1-year cliff.
Director options vested 1/4 immediately, remainder quarterly; vesting may accelerate on FDA clearance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.